Gamma interferon (IFN-␥) is a cytokine which plays a critical role in resistance to
Tuberculosis remains an important cause of morbidity and mortality worldwide. Mycobacterium tuberculosis, the etiologic agent of tuberculosis, is responsible for more human deaths each year than any other single pathogen. Initially, establishment of a productive infection depends on the bacterium's ability to invade the alveolar space and survive within the aleolar macrophages (AM). Infection of AM by M. tuberculosis rapidly leads to the activation of AM, the production of cytokines that serve to limit the growth of ingested organisms, and the recruitment of additional leukocytes from the peripheral circulation (reviewed in reference 17). While innate immune responses predominate initially, the subsequent recruitment of T lymphocytes to the lung is vital to the containment of M. tuberculosis within granulomas (reviewed in reference 31). Cytokines produced by T cells, such as gamma interferon (IFN-␥), can activate monocytes and macrophages to become microbicidal (6) . Ineffective immunity against mycobacterial infection is associated with a depressed Th1 cytokine response and reduced production of IFN-␥ (40, 43) .
IFN-␥ is thought to be a principal mediator of macrophage activation and resistance to intracellular pathogens (reviewed in reference 41). Exposure of macrophages to IFN-␥ results in increased expression of major histocompatibility complex class II molecules and the potentiation of a variety of cellular responses. These responses include cytokine production, nitric oxide (NO) production, and cytolytic activity (reference 41 and references therein). At least in mice, the production of NO is a powerful antimicrobial response to M. tuberculosis infection (7) . IFN-␥ plays a critical role in priming macrophages to generate NO in vitro. The importance of IFN-␥ in the resistance to M. tuberculosis infection was most clearly shown with mice that are homozygous for a targeted disruption of the IFN-␥ gene (9, 10, 18) . Upon infection, these mutant mice developed granulomas, failed to produce NO, and were unable to restrict disseminated growth of the bacilli. Treatment of these mice with exogenous IFN-␥ delayed, but could not prevent, the fatal course of tuberculosis (18) . The importance of IFN-␥ in human tuberculosis is suggested by the increased susceptibility to mycobacterial infection in persons with mutations of the IFN-␥ receptor 1 that resulted in reduced receptor expression and IFN-␥ unresponsiveness (24, 30) .
The production of IFN-␥ has been generally considered to be restricted to T cells and natural killer (NK) cells. Several investigators have demonstrated that murine macrophages can also express IFN-␥ following treatment with either lipopolysaccharide (LPS), cycloheximide, or IFN-␥ itself (12, 21) . In contrast, IFN-␥ has not been shown to upregulate its own expression in murine lymphocytes or in human blood monocytes (12) . These studies prompted us to test the possibility that human AM could be induced to express IFN-␥. In this work, we show that M. tuberculosis stimulates the production of IFN-␥ by AM and that IFN-␥ mRNA can also be induced in uninfected cells by IFN-␥ protein or interleukin-12 (IL-12) but not by LPS. Data suggesting that macrophage-derived IFN-␥ can function in an autocrine and/or paracrine manner toward AM are presented. Lastly, we found that IL-10 could suppress M. tuberculosis-induced IFN-␥. Together, our studies suggest that IFN-␥ produced by AM may play a role in innate immunity against tuberculosis.
MATERIALS AND METHODS

Antibodies and reagents.
A blocking rabbit anti-human IFN-␥ antiserum (AHC4734) and normal rabbit serum were purchased from Biosource International (Camarillo, Calif.). Recombinant human IL-10 was a generous gift from Raymond Donnelly (Division of Cytokine Biology, U.S. Food and Drug Administration). Recombinant human IFN-␥ and IL-12 and a blocking goat anti-IL-12 antiserum (AB-219-NA) were purchased from R & D Systems (Minneapolis, Minn.). DNA oligonucleotide primers were purchased from Gibco-BRL (Grand Island, N.Y.).
Isolation and infection of human AM. Human AM were prepared from bronchoalveolar lavage (BAL) fluids obtained from purified protein derivativenegative, nonsmoking volunteers. BAL was performed after informed consent was obtained according to protocols approved by the Institutional Review Board. After local anesthesia was obtained with topical 2% lidocaine, an Olympus flexible fiberoptic bronchoscope (model BF-4B2) was introduced by the transoral route and wedged into a subsegment of the right middle lobe. Sterile 0.9% NaCl was instilled in 60-ml aliquots and aspirated, with a total of 240 ml of saline. Lavage fluid was filtered through a single layer of sterile gauze and then centrifuged (300 ϫ g at room temperature), and cells were suspended at 10 6 cells/ml in RPMI 1640 culture medium (BioWhittaker, Walkersville, Md.) supplemented with 10% heat-inactivated fetal bovine serum (Defined FBS; HyClone Laboratories, Logan, Utah), 10 mM HEPES, 2 mM L-glutamine, and 50 mg of cefotaxime per ml (complete medium). Endotoxin levels of all medium components were less than 20 pg/ml (final concentration). Adherent cells obtained by this procedure were Ͼ99% AM, as determined by morphologic examination and ␣-naphthyl acetate esterase staining. Other controls for lymphocyte contamination are discussed below. AM (2 ϫ 10 6 cells) were maintained in 60-mm-diameter dishes containing 3 ml of complete medium in a humidified incubator at 37°C and 5% CO 2 for 6 days prior to use. Before each experiment, the culture supernatants were aspirated and replaced with fresh complete medium. M. tuberculosis H37Rv (ATCC 25618) and H37Ra (ATCC 25177) were obtained from the American Type Culture Collection (Rockville, Md.) and were cultured at 37°C in Middlebrook 7H9 medium supplemented with Tween 80 and albumin, dextrose, and catalase under biosafety level 3 conditions. Following vigorous dispersion (25) , viable bacilli were added to the macrophage cultures (2 ϫ 10 6 to 3 ϫ 10 6 cells) at an infectivity ratio of approximately 10:1 for various times, as indicated in the text. Culture supernatants were harvested, filtered through 0.22-mm-pore-size filters to remove any bacilli and debris, and then stored in frozen aliquots at Ϫ30°C. Cytokine levels in these supernatants were measured as described below. Adherent cells were lysed on the dishes by the addition of 2 ml of Tri-Reagent (Molecular Research, Cincinnati, Ohio). Total RNA was purified from these lysates as recommended by the manufacturer.
Measurement of cytokine and nitrite levels. Tumor necrosis factor alpha (TNF-␣) and IFN-␥ levels in culture supernatants were measured in duplicate by enzyme-linked immunosorbent assay (ELISA) (R & D Systems) as recommended by the manufacturer. Levels of IFN-␥-inducible protein-10 (IP-10) and monokine induced by IFN-␥ (MIG) were measured in duplicate by ELISA as described previously (1) . Each experiment used AM from a single donor, and at least three experiments were performed. Results from a single experiment are shown in this work. The standard error of the mean was less than 10% in all experiments shown. To assess NO production, the culture supernatants were assayed for the stable metabolite of NO, nitrite. Nitrite levels were measured by using the Greiss reaction, as previously described (23) .
Reverse transcription-PCR (RT-PCR). Total RNA was reverse transcribed with murine Moloney leukemia virus reverse transcriptase (Gibco-BRL) and oligo(dT) (Promega, Madison, Wis.) as recommended by the manufacturer. The resulting cDNA was quantitated by spectrophotometry. The cDNA (0.5 to 3 g per reaction) was amplified by PCR in a 100-l reaction mixture containing 1 mM primers, 20 mM nucleoside triphosphates, 2.5 mM MgCl 2 , and 2.5 U of Taq polymerase (Promega). Amplifications were carried out for 30 cycles; the parameters for each cycle were 1 min at 95°C, 1 min at 60°C, and 1.5 min at 72°C. The products were then run on a 1.5% agarose gel and stained with ethidium bromide. The sequences of the human ␤-actin oligonucleotide primers which were used to generate a 504-bp PCR product are 5Ј-ATGCCATCCTGCGTCT GGA-3Ј (sense strand) and 5Ј-CACATCTGCTGGAAGGTGG-3Ј (antisense strand). The sequences of the human glyceraldehyde phosphate dehydrogenase oligonucleotide primers which were used to generate a 983-bp PCR product are 5Ј-TGAAGGTCGGAGTCAACGGATTTGGT-3Ј (sense strand) and 5Ј-CATG TGGGCCATGAGGTCCACCAC-3Ј (antisense strand). The sequences of the human IFN-␥ primers which were used to generate a 470-bp PCR product are 5Ј-ATGAAATATACAAGTTATATCTTGGCTTTT-3Ј (sense strand) and 5Ј-G ATGCTCTTCGACCTTGAAACAGCAT-3Ј (antisense strand).
For RT-in situ PCR analysis, 1.5 ϫ 10 4 AM were fixed onto silane-coated slides (Cell-Line Associates Inc., New Field, Conn.) with 10% buffered formalin. After digestion with proteinase K (100 g/ml; Sigma, St. Louis, Mo.), RNase-free DNase I (1 U/ml; Boehringer Mannheim, Indianapolis, Ind.) was added and allowed to incubate overnight at room temperature. The RNA was reverse transcribed under the same conditions as described above. The cDNA was then amplified by addition of 25 l of the PCR mixture described above, supplemented with 2% bovine serum albumin and 1 mM digoxigenin-11-dUTP (Boehringer Mannheim). In some experiments, primers specific for human IL-2 were used as a control for contaminating lymphocytes. PCR was carried out for 30 cycles with the cycle parameters described above. The PCR products were then treated with alkaline phosphatase-labeled antidigoxigenin antibody (Boehringer Mannheim). Final detection of the PCR products was achieved by adding 4-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl-phosphate (Promega). A nuclear fast red counterstain (Shandon Lipshaw, Pittsburgh, Pa.) was then added to each slide.
RESULTS
Cytokine production by M. tuberculosis-stimulated AM. Previous reports that murine macrophages can secrete IFN-␥ prompted us to determine if human macrophages could also release this cytokine. Human AM were prepared as described above and incubated for 24 h in the presence of a virulent (H37Rv) or attenuated (H37Ra) strain of M. tuberculosis at an infectivity ratio of approximately 10:1. Following exposure of the AM to M. tuberculosis, culture supernatants were collected and cytokine levels were measured by ELISA. As shown in Fig. 1 , unstimulated AM spontaneously release minimal amounts of TNF-␣ and IFN-␥ ( Fig. 1A and B, respectively) into the culture medium. H37Ra and H37Rv appeared to be equally capable of inducing release of both cytokines. In contrast, H37Ra consistently induced nitrite release whereas H37Rv did not induce nitrite release (Fig. 1C ). While this nitrite may be generated by the breakdown of M. tuberculosisinduced NO, nitrite release could not be blocked by the inducible NO synthase inhibitor N-monomethyl arginine or 2-aminoguanidine (data not shown). Substantial donor variability in the levels of M. tuberculosis-induced IFN-␥ was observed. IFN-␥ levels measured in six experiments using AM from different donors ranged from 395 to 4,532 pg/ml (after 48 h of stimulation). We subsequently measured the kinetics of IFN-␥ and TNF-␣ release by AM stimulated with H37Ra for 4, 8, 24, and 48 h. As shown in Fig. 2 , TNF-␣ accumulates rapidly in the culture medium, with peak levels observed by 8 h after stimulation. In contrast, IFN-␥ levels accumulate in the culture medium at a lower rate. Together, these studies show that IFN-␥ is released into the culture supernatants of M. tuberculosis-stimulated AM.
M. tuberculosis and IFN-␥ protein induce the expression of IFN-␥ mRNA in AM. RT-PCR was used to evaluate IFN-␥ mRNA expression by AM at various times after stimulation with M. tuberculosis. Total RNA was prepared from the adherent AM that were used to generate the culture supernatants described in Fig. 2 . This RNA was analyzed by RT-PCR as described above, with IFN-␥-and ␤-actin-specific primers. As shown in Fig. 3A , cDNA prepared from unstimulated AM RNA (designated 0 h) did not generate a PCR product of the predicted size when the IFN-␥ primers were used. A PCR product of the predicted size was observed when cDNA prepared from H37Ra-stimulated cells was used. The specificity of this PCR product was confirmed by DNA sequencing (data not shown). IFN-␥ mRNA levels were maximal between 8 and 24 h and were markedly reduced by 48 h. Levels of control (␤-actin) mRNA were essentially identical at all time points tested. No PCR products were observed when primers were not included in the RT-PCRs (data not shown). These data demonstrate that IFN-␥ mRNA is rapidly induced and transiently expressed in M. tuberculosis-stimulated AM.
One earlier study reported that IFN-␥ could upregulate its own gene expression in murine resident peritoneal macrophages (12) . We used RT-PCR to characterize IFN-␥ mRNA expression in unstimulated AM and in cells stimulated with IFN-␥ protein (100 U/ml) for 48 h. As shown in Fig. 3B, IFN Identification of IFN-␥-producing AM by RT-in situ PCR. Cells from the BAL fluids of normal volunteers are typically Ն90% AM. These BAL cells were further enriched for AM by adherence. Furthermore, the cells were cultured for 6 days prior to the experiment, and any additional nonadherent cells were removed by washing prior to M. tuberculosis stimulation. The resulting cells averaged Ͼ99% macrophages as judged by nonspecific esterase staining. In order to determine if the source of IFN-␥ in these M. tuberculosis-stimulated cultures was the AM or the Ͻ1% contaminating lymphocytes, we examined IFN-␥ mRNA expression in individual cells by RT-in situ PCR. Because of the counterstain used, AM could be easily distinguished from any contaminating lymphocytes by virtue of their characteristic size and morphology. Human peripheral blood T cells stimulated with phorbol esters and ionomycin were used as a positive PCR control for IFN-␥ expression (data not shown). As shown in Fig. 4a , unstimulated AM did not contain detectable IFN-␥ mRNA. Following 24 h of stimulation with H37Ra, more than 80% of the AM contained IFN-␥ mRNA (Fig. 4b) . No IL-2 expression was observed in these infected cultures (Fig. 4c) , indicating that there was no substantial contamination of the AM by T or NK cells. No signal was observed when digoxigenin-11-dUTP was not included in the PCRs, indicating that endogenous alkaline phosphatase activity was not responsible for the positive IFN-␥ signal observed in M. tuberculosis-infected cells (Fig. 4d ). These studies demonstrate that the predominant cells which express IFN-␥ in these cultures are the AM.
IFN-␥-dependent production of chemokines by M. tuberculosis-stimulated AM. IP-10 and MIG are chemokines that are secreted by IFN-␥-stimulated monocytes (15, 27, 28) . We hypothesized that if IFN-␥ could act on AM in an autocrine or paracrine manner, this would result in the expression of these IFN-inducible chemokines. In order to test this possibility, we stimulated AM with H37Ra for 48 h in the presence and Total RNA was prepared from the adherent AM which were used to generate the culture supernatants described in the legend to Fig. 2 . This RNA was used to generate reverse-transcribed cDNA, which was analyzed by RT-PCR using IFN-␥-and ␤-actin-specific PCR primers as described in the text. PCR products were fractionated by agarose gel electrophoresis and visualized by staining with ethidium bromide. mkr, molecular size marker. (B) RT-PCR was used to compare IFN-␥ mRNA expression in unstimulated AM (2 ϫ 10 6 cells/well) and cells stimulated with IFN-␥ protein (100 U/ml) for 48 h. Total RNA was used to generate reverse-transcribed cDNA, which was analyzed by RT-PCR using IFN-␥-and GAPDH-specific PCR primers as described in the text. PCR products were fractionated by agarose gel electrophoresis and visualized by staining with ethidium bromide.
VOL. 65, 1997 IFN-␥ PRODUCTION BY HUMAN ALVEOLAR MACROPHAGES 5151
on August 28, 2017 by guest http://iai.asm.org/ Downloaded from absence of a neutralizing anti-IFN-␥ antiserum (1 mg/ml). Culture supernatants were then harvested and assayed for IFN-␥, IP-10, MIG, and TNF-␣ by ELISA. As shown in Fig. 5 , H37Ra was a potent inducer of each cytokine. A substantial reduction in IFN-␥ levels was observed in the supernatants of AM cultures stimulated with H37Ra in the presence of the anti-IFN-␥ antiserum (Fig. 5A) . Similarly, IP-10 and MIG production was markedly reduced (Fig. 5B and C) . The anti-IFN-␥ antiserum had no significant effect on TNF-␣ production (Fig.  5D) , and normal rabbit serum had no effect on M. tuberculosisinduced cytokine levels (data not shown). These data suggest that M. tuberculosis-induced IFN-␥ can induce IP-10 and MIG production in an autocrine and/or paracrine manner and that the expression of these chemokines does not result from M. tuberculosis-induced TNF-␣ (32).
Effect of IL-10 on M. tuberculosis-induced cytokine production by AM. IL-10 is a likely mediator of the depressed IFN-␥ response in diseases caused by intracellular pathogens, including M. tuberculosis (22) . IL-10 has been previously reported to suppress the production of several LPS-inducible macrophage cytokines, including IL-1␤, TNF-␣, and IL-6 (17, 29) . We questioned whether IL-10 could also suppress M. tuberculosis-inducible IFN-␥ production by AM. AM were infected in vitro with H37Ra and then incubated for 48 h in the presence or absence of recombinant human IL-10 (20 ng/ml). Culture supernatants were collected and assayed for IFN-␥, IP-10, and MIG as described above. As shown in Fig. 6A , IL-10 was capable of suppressing M. tuberculosis-induced IFN-␥ production. Chemokine production was similarly suppressed (Fig. 6B  and C) , perhaps due to the reduction of IFN-␥ production. The specificity of these responses was addressed by the finding that a neutralizing anti-IL-10 antiserum could reverse the suppressive effect of IL-10 on M. tuberculosis-induced IFN-␥ production (data not shown).
Effect of IL-12 on M. tuberculosis-induced IFN-␥ production by AM. A recent study reported that IL-12 could directly induce IFN-␥ production by murine peritoneal macrophages (33) . In addition, IL-12 has been shown to be produced by M. tuberculosis-stimulated peripheral blood mononuclear cells (PBMC) and is present in the pleural fluids of patients with tuberculous pleuritis (19, 44) . We tested the possibility that M. tuberculosis-induced IFN-␥ might occur as a consequence of M. tuberculosis-induced IL-12 production. AM were stimulated with H37Ra in the presence and absence of neutralizing anti-IL-12 antibodies for 48 h. Culture supernatants were collected and assayed for IFN-␥ as described above. As shown in Fig. 7A, anti-IL-12 antibodies markedly reduced the levels of IFN-␥ produced by the M. tuberculosis-stimulated AM. In addition, exogenous IL-12 (20 U/ml) was capable of stimulating these cells to secrete large amounts of IFN-␥ (Fig. 7B) . Together, these data suggest that M. tuberculosis-induced IL-12, as well as exogenous IL-12, can activate IFN-␥ production by AM.
LPS fails to induce IFN-␥ production by AM. Previous studies have shown that LPS-stimulated murine thioglycolateelicited peritoneal macrophages and macrophage colony-stimulating factor-derived bone marrow macrophages could express IFN-␥ (21). In contrast, resident murine peritoneal macrophages failed to produce IFN-␥ in response to LPS alone (12) . Our studies showed that LPS stimulation (100 ng/ml; 48 h) failed to induce IFN-␥ release by AM (Fig. 8A) . As expected, LPS did induce substantial TNF-␣ release (Fig. 8B) . This finding suggests that LPS alone and LPS-inducible cytokines are not sufficient to induce IFN-␥ production by human AM. This conclusion is consistent with our observation that the presence of a neutralizing anti-TNF-␣ monoclonal antibody did not affect IFN-␥ production in M. tuberculosis-stimulated AM (data not shown). (21) showed that LPS-stimulated murine thioglycolate-elicited peritoneal macrophages from C3H/OuJ mice expressed IFN-␥ mRNA and immunoreactive IFN-␥ protein. These investigators also showed that macrophage colony-stimulating factorderived murine bone marrow macrophages could also express IFN-␥ mRNA following LPS stimulation. In contrast, peritoneal macrophages from LPS-hyporesponsive C3H/HeJ mice did not express IFN-␥ following LPS stimulation, whereas peritoneal macrophages from both mouse strains were able to produce comparable levels of IFN-␥ mRNA following stimulation with polyinosinic-polycytidylic acid [poly(I)-poly(C)].
Di Marzio et al. (12) later showed that resident murine peritoneal macrophages could produce IFN-␥ mRNA following treatment with either cycloheximide or IFN-␥ protein.
Moreover, IFN-␥ did not induce its own expression in murine lymphocytes or in human peripheral blood monocytes. In contrast, our findings demonstrate that IFN-␥ protein can induce IFN-␥ mRNA production in AM. These differences may reflect the differentiation state of the AM or perhaps previous exposure of AM to modulating signals, such as extracellular matrix proteins encountered during migration from the circulation. Differences in the relative responsiveness of AM and peripheral blood monocytes to stimuli have frequently been reported (3, 4, 26, 34, 35) . Our demonstration that exogenous IFN-␥ can induce its own expression further supports our conclusion that AM are the source of IFN-␥ in these cultures, because lymphocytes do not express this cytokine in response to exogenous IFN-␥. Our studies also revealed that LPS alone could not induce AM to secrete IFN-␥. Similarly, resident murine peritoneal macrophages reportedly failed to produce IFN-␥ in response to LPS alone (12) . These findings contrast with an earlier study reporting that LPS could stimulate thioglycolate-elicited peritoneal macrophages to produce IFN-␥ (21). Furthermore, resident peritoneal macrophages primed in vitro with IFN-␥ became capable of producing IFN-␥ in response to LPS. Recently, Fultz and Vogel reported that IFN-␣ could induce IFN-␥ expression in elicited murine peritoneal macrophages and vice versa. Furthermore, these investigators showed that in vitro priming of C3H/OuJ peritoneal macrophages with either LPS or IFN-␣ resulted in a synergistic increase in the amount of IFN-␥ produced following stimulation with poly(I)-poly(C). In contrast, priming of C3H/HeJ peritoneal macrophages with IFN-␣ but not with LPS could augment the production of IFN-␥ following poly(I)-poly(C) stimulation. Thus, priming may modulate the ability of macrophages to express IFN-␥ in response to LPS (20) .
IL-10 and IL-12 are both known to be released by M. tuberculosis-stimulated macrophages (19, 22, 32) , although these cytokines appear to have opposing effects on IFN-␥ production. We have demonstrated that IL-10 suppresses M. tuberculosis-induced IFN-␥ production by AM, whereas IL-12 can directly induce IFN-␥ production by uninfected cells. Furthermore, anti-IL-12 antibodies could suppress M. tuberculosisinduced IFN-␥ production, suggesting that M. tuberculosis may indirectly induce IFN-␥ production via the ability of the bacilli to induce IL-12 production. Our data are consistent with a model in which the level of IFN-␥ produced by M. tuberculosisstimulated AM is regulated by the balance between the levels of IL-10 and IL-12. Neutralizing antibodies against IL-10 have been shown to enhance IFN-␥ production by PBMC from tuberculosis patients by enhancing IL-12 production (22), although IL-10 itself was not overproduced by these cells in vitro relative to PBMC from healthy tuberculin responders (43) . IL-12 has been recently reported to induce IFN-␥ production directly in murine peritoneal macrophages (33) . It should also be noted that IFN-␥ is a potent suppressor of IL-10 expression by human monocytes (8, 13) . Conversely, IL-10 inhibits the expression of several proinflammatory cytokines by monocytic cells (17, 39, 44) . IL-10 has been shown to inhibit the produc- tion of IL-2 mRNA but not IFN-␥ mRNA in activated human peripheral blood T cells (29) . This contrasts with our finding that IL-10 can suppress the production of IFN-␥ by M. tuberculosis-activated AM. Roles for IL-10 and IL-12 in the regulation of IFN-␥ production by AM in vivo remain to be determined.
Macrophage cytokines are critically important in the control of tuberculosis (reviewed in reference 40). A central role for IFN-␥ as a macrophage activating factor in mycobacterial infections has been clearly demonstrated in the mouse (reviewed in reference 16). Exposure of macrophages to IFN-␥ results in increased expression of major histocompatibility complex class II molecules and the augmentation of cytokine production, NO production, and cytolytic activity (reviewed in reference 42). At least in mice, the production of NO is a powerful antimicrobial response to M. tuberculosis infection (7), although its role in human tuberculosis remains unclear. The importance of IFN-␥ in the resistance to M. tuberculosis infection was best shown with mice which are homozygous for a targeted disruption of the IFN-␥ gene (9, 18) . Upon infection, these mutant mice developed granulomas, failed to produce NO, and were unable to restrict disseminated growth of the bacilli.
In human studies, IFN-␥ failed to inhibit mycobacterial growth consistently within monocytic cells in vitro in the absence of other cytokines (12, 37) . Some studies have reported that IFN-␥ actually enhanced intracellular mycobacterial growth in vitro (5, 14) . Levels of IFN-␥ were reported to be elevated in the pleural fluid of patients with tuberculous pleuritis (2, 38) , yet IFN-␥ production by stimulated PBMC from tuberculosis patients was significantly reduced compared with that of healthy tuberculin responders (43) . Nonetheless, the enhanced susceptibility to mycobacterial infection in persons with mutations of IFN-␥ receptor 1 is powerful evidence that IFN-␥ is critically involved in the control of human tuberculosis (24, 30) . Thus, IFN-␥ production by AM may be part of the normal host response against this pathogen. It is interesting that exposure of AM to Cryptococcus neoformans, a distinct lung pathogen, did not induce IFN-␥ production (data not shown). This suggests that intracellular pathogens, such as M. tuberculosis, induce innate immune responses that are distinct from those induced by extracellular pathogens.
A commonly accepted model of human tuberculosis holds that AM are ineffective at controlling initial infection. After recruitment of lymphocytes and stimulation with lymphocytederived IFN-␥, a protective response is developed. The finding that M. tuberculosis-infected AM themselves are a source of IFN-␥ and that these cells respond in an autocrine and/or paracrine fashion suggests that this model should be revised. Future studies are needed to address the relative contribution of macrophage-derived IFN-␥ to the microbicidal activities of M. tuberculosis-infected AM and ultimately to the course of tuberculosis disease.
